ANGIOTENSIN CONVERTING ENZYME INHIBITION AND NOVEL CARDIOVASCULAR RISK BIOMARKERS: Results from the TRAIN study

BACKGROUND: Beneficial effects of angiotensin converting enzyme (ACE) inhibitors seem to be mediated by mechanisms that are partly independent of blood pressure lowering. The present study evaluates effects of an ACE-inhibitor (i.e. fosinopril) intervention on novel cardiovascular risk factors. METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Heart J
Main Authors: Cesari, Matteo, Kritchevsky, Stephen B., Atkinson, Hal H., Penninx, Brenda W., Di Bari, Mauro, Tracy, Russell P., Pahor, Marco
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384444/
https://ncbi.nlm.nih.gov/pubmed/19185642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.10.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados